Summary: From Feb. to March, China’s ex-works price of emamectin benzoate technical went up mainly because of tight supply of the product brought about by low operating rates in the manufacturers in Hubei Province as well as restricted transportation affected by the COVID-19 outbreak. Moreover, demand for emamectin benzoate technical increased as Spodoptera frugiperda occurred.